$PAVM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PAVmed Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PAVmed Inc.. Get notifications about new insider transactions in PAVmed Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | PAVM | PAVmed Inc. | Battleman David S. | Director | Option Exercise | A | 4.44 | 50,000 | 222,000 | 50,000 | |
| Apr 05 2021 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | President & CFO | Grant | A | 0.00 | 150,000 | 0 | 955,462 | 805.5 K to 955.5 K (+18.62 %) |
| Apr 05 2021 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Grant | A | 0.00 | 150,000 | 0 | 1,255,913 | 1.1 M to 1.3 M (+13.56 %) |
| Mar 19 2021 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 4.31 | 7,500 | 32,324 | 1,105,913 | 1.1 M to 1.1 M (+0.68 %) |
| Nov 27 2020 | PAVM | PAVmed Inc. | SIROVICH MATTHEW | 10% Owner | Sell | S | 1.96 | 33,203 | 65,048 | 1,027,744 | 1.1 M to 1 M (-3.13 %) |
| Nov 27 2020 | PAVM | PAVmed Inc. | SIROVICH MATTHEW | 10% Owner | Sell | S | 2.00 | 53,036 | 105,876 | 1,060,947 | 1.1 M to 1.1 M (-4.76 %) |
| Jun 01 2020 | PAVM | PAVmed Inc. | SIROVICH MATTHEW | 10% Owner | Sell | S | 1.98 | 131,082 | 259,477 | 1,213,983 | 1.3 M to 1.2 M (-9.75 %) |
| Jun 01 2020 | PAVM | PAVmed Inc. | SIROVICH MATTHEW | 10% Owner | Sell | S | 2.06 | 69,839 | 143,666 | 1,345,065 | 1.4 M to 1.3 M (-4.94 %) |
| May 04 2020 | PAVM | PAVmed Inc. | Weild IV David | Director | Option Exercise | A | 2.19 | 100,000 | 219,000 | 100,000 | |
| May 04 2020 | PAVM | PAVmed Inc. | Sparks Ronald M | Director | Option Exercise | A | 2.19 | 100,000 | 219,000 | 100,000 | |
| May 04 2020 | PAVM | PAVmed Inc. | Glennon Michael J | Vice Chairman | Option Exercise | A | 2.19 | 100,000 | 219,000 | 100,000 | |
| May 04 2020 | PAVM | PAVmed Inc. | DeGuzman Brian J. | Chief Medical Offic ... | Option Exercise | A | 2.19 | 50,000 | 109,500 | 50,000 | |
| May 04 2020 | PAVM | PAVmed Inc. | Cox James L | Director | Option Exercise | A | 2.19 | 100,000 | 219,000 | 100,000 | |
| May 04 2020 | PAVM | PAVmed Inc. | Battleman David S. | Director | Option Exercise | A | 2.19 | 100,000 | 219,000 | 100,000 | |
| May 04 2020 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Grant | A | 0.00 | 250,000 | 0 | 1,098,413 | 848.4 K to 1.1 M (+29.47 %) |
| May 04 2020 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | President & CFO | Grant | A | 0.00 | 250,000 | 0 | 791,704 | 541.7 K to 791.7 K (+46.15 %) |
| Feb 03 2020 | PAVM | PAVmed Inc. | SIROVICH MATTHEW | 10% Owner | Option Exercise | X | 0.01 | 1,199,383 | 11,994 | 0 | |
| Feb 03 2020 | PAVM | PAVmed Inc. | SIROVICH MATTHEW | 10% Owner | Buy | X | 0.01 | 1,199,383 | 11,994 | 1,938,297 | 738.9 K to 1.9 M (+162.32 %) |
| May 28 2019 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | President & CFO | Buy | P | 1.09 | 5,000 | 5,429 | 529,000 | 524 K to 529 K (+0.95 %) |
| May 28 2019 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 1.10 | 30,000 | 32,850 | 848,413 | 818.4 K to 848.4 K (+3.67 %) |
| Mar 19 2019 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Grant | A | 0.00 | 200,000 | 0 | 818,413 | 618.4 K to 818.4 K (+32.34 %) |
| Mar 19 2019 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Grant | A | 0.00 | 500,000 | 0 | 524,000 | 24 K to 524 K (+2,083.33 %) |
| Mar 12 2019 | PAVM | PAVmed Inc. | Cox James L | Director | Option Exercise | A | 1.00 | 200,000 | 200,000 | 200,000 | |
| Mar 12 2019 | PAVM | PAVmed Inc. | Battleman David S. | Director | Option Exercise | A | 1.00 | 200,000 | 200,000 | 200,000 | |
| Mar 11 2019 | PAVM | PAVmed Inc. | Glennon Michael J | Vice Chairman | Option Exercise | A | 1.00 | 200,000 | 200,000 | 200,000 | |
| Mar 11 2019 | PAVM | PAVmed Inc. | Sparks Ronald M | Director | Option Exercise | A | 1.00 | 200,000 | 200,000 | 200,000 | |
| Mar 11 2019 | PAVM | PAVmed Inc. | DeGuzman Brian J. | Chief Medical Offic ... | Option Exercise | A | 1.00 | 100,000 | 100,000 | 100,000 | |
| Mar 11 2019 | PAVM | PAVmed Inc. | Weild IV David | Director | Option Exercise | A | 1.00 | 200,000 | 200,000 | 200,000 | |
| Jan 28 2019 | PAVM | PAVmed Inc. | SIROVICH MATTHEW | 10% Owner | Buy | J | 0.00 | 60,000 | 0 | 792,000 | 732 K to 792 K (+8.20 %) |
| Jan 28 2019 | PAVM | PAVmed Inc. | SIROVICH MATTHEW | 10% Owner | Buy | J | 0.00 | 272,400 | 0 | 738,914 | 466.5 K to 738.9 K (+58.39 %) |
| Aug 28 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 1.18 | 30,000 | 35,400 | 618,413 | 588.4 K to 618.4 K (+5.10 %) |
| Jul 12 2018 | PAVM | PAVmed Inc. | DeGuzman Brian J. | Chief Medical Offic ... | Option Exercise | J | 1.60 | 322,673 | 516,277 | 0 | |
| Jul 12 2018 | PAVM | PAVmed Inc. | DeGuzman Brian J. | Chief Medical Offic ... | Option Exercise | J | 1.60 | 322,673 | 516,277 | 322,673 | |
| Jul 11 2018 | PAVM | PAVmed Inc. | Glennon Michael J | Vice Chairman | Option Exercise | J | 1.60 | 322,673 | 516,277 | 0 | |
| Jul 11 2018 | PAVM | PAVmed Inc. | Glennon Michael J | Vice Chairman | Option Exercise | J | 1.60 | 322,673 | 516,277 | 322,673 | |
| Jul 11 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | J | 1.60 | 968,019 | 1,548,830 | 2,078,285 | |
| Jul 11 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | X | 1.60 | 980 | 1,568 | 980 | |
| Jul 11 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | X | 1.15 | 980 | 1,127 | 0 | |
| Jul 11 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | X | 1.60 | 1,018 | 1,629 | 1,018 | |
| Jul 11 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | X | 1.15 | 1,018 | 1,171 | 0 | |
| Jul 11 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | G | 1.60 | 12,450 | 19,920 | 363,313 | |
| Jul 11 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | X | 0.00 | 980 | 0 | 2,280 | 1.3 K to 2.3 K (+75.38 %) |
| Jul 11 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | X | 0.00 | 1,018 | 0 | 2,303 | 1.3 K to 2.3 K (+79.22 %) |
| Jun 11 2018 | PAVM | PAVmed Inc. | Greenspan Ira Scott | 10% Owner | Sell | S | 1.04 | 18,300 | 19,032 | 421,691 | 440 K to 421.7 K (-4.16 %) |
| Jun 05 2018 | PAVM | PAVmed Inc. | Greenspan Ira Scott | 10% Owner | Sell | S | 0.97 | 532,255 | 516,287 | 439,991 | 972.2 K to 440 K (-54.74 %) |
| Apr 09 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | A | 3.00 | 10,000 | 30,000 | 10,000 | |
| Apr 09 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | D | 5.00 | 20,000 | 100,000 | 0 | |
| Apr 09 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | A | 3.00 | 1,110,266 | 3,330,798 | 1,110,266 | |
| Apr 09 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | D | 5.00 | 2,220,532 | 11,102,660 | 0 | |
| Apr 09 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | A | 3.00 | 2,823,281 | 8,469,843 | 2,823,281 | |
| Apr 09 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | D | 5.00 | 5,646,562 | 28,232,810 | 0 | |
| Apr 09 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | A | 3.00 | 25,225 | 75,675 | 25,225 | |
| Apr 09 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | D | 5.00 | 50,450 | 252,250 | 0 | |
| Feb 16 2018 | PAVM | PAVmed Inc. | Battleman David S. | Director | Option Exercise | A | 2.01 | 100,000 | 201,000 | 100,000 | |
| Feb 16 2018 | PAVM | PAVmed Inc. | Weild IV David | Director | Option Exercise | A | 2.01 | 100,000 | 201,000 | 100,000 | |
| Feb 16 2018 | PAVM | PAVmed Inc. | Glennon Michael J | Vice Chairman | Option Exercise | A | 2.01 | 100,000 | 201,000 | 100,000 | |
| Feb 16 2018 | PAVM | PAVmed Inc. | DeGuzman Brian J. | Chief Medical Offic ... | Option Exercise | A | 2.01 | 100,000 | 201,000 | 100,000 | |
| Feb 16 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | A | 2.01 | 195,108 | 392,167 | 195,108 | |
| Feb 16 2018 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Gift | G | 0.00 | 34,153 | 0 | 588,413 | 622.6 K to 588.4 K (-5.49 %) |
| Feb 16 2018 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Option Exercise | A | 2.01 | 195,108 | 392,167 | 195,108 | |
| Jan 03 2018 | PAVM | PAVmed Inc. | DeGuzman Brian J. | Chief Medical Offic ... | Sell | J | 0.00 | 645,346 | 0 | 0 | 645.3 K to 0 (-100.00 %) |
| Jan 03 2018 | PAVM | PAVmed Inc. | DeGuzman Brian J. | Chief Medical Offic ... | Buy | J | 0.00 | 645,346 | 0 | 645,346 | 0 to 645.3 K |
| Dec 29 2017 | PAVM | PAVmed Inc. | Glennon Michael J | Vice Chairman | Sell | J | 0.00 | 645,346 | 0 | 0 | 645.3 K to 0 (-100.00 %) |
| Dec 29 2017 | PAVM | PAVmed Inc. | Glennon Michael J | Vice Chairman | Buy | J | 0.00 | 645,346 | 0 | 645,346 | 0 to 645.3 K |
| Dec 26 2017 | PAVM | PAVmed Inc. | Lamstein Joshua R | Director | Buy | J | 0.00 | 79,560 | 0 | 163,177 | 83.6 K to 163.2 K (+95.15 %) |
| Nov 27 2017 | PAVM | PAVmed Inc. | Greenspan Ira Scott | Director | Option Exercise | J | 5.00 | 67,317 | 336,585 | 5,646,562 | |
| Nov 27 2017 | PAVM | PAVmed Inc. | Greenspan Ira Scott | Director | Sell | J | 0.00 | 67,317 | 0 | 5,646,562 | 5.7 M to 5.6 M (-1.18 %) |
| Nov 27 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | J | 5.00 | 67,317 | 336,585 | 5,646,562 | |
| Nov 27 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Sell | J | 0.00 | 67,317 | 0 | 5,646,562 | 5.7 M to 5.6 M (-1.18 %) |
| Nov 27 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | L | 4.30 | 1,200 | 5,160 | 71,489 | 70.3 K to 71.5 K (+1.71 %) |
| Nov 21 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 950 | 0 | 70,289 | 69.3 K to 70.3 K (+1.37 %) |
| Nov 21 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 601 | 0 | 69,339 | 68.7 K to 69.3 K (+0.87 %) |
| Sep 21 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 2,600 | 0 | 68,738 | 66.1 K to 68.7 K (+3.93 %) |
| Sep 14 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 100 | 500 | 50,400 | |
| Sep 14 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 200 | 1,000 | 50,300 | |
| Sep 14 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 300 | 0 | 66,138 | 65.8 K to 66.1 K (+0.46 %) |
| Sep 14 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 6.66 | 100 | 666 | 65,838 | 65.7 K to 65.8 K (+0.15 %) |
| Sep 14 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 300 | 0 | 65,738 | 65.4 K to 65.7 K (+0.46 %) |
| Sep 11 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 300 | 1,500 | 50,100 | |
| Sep 11 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 200 | 1,000 | 49,800 | |
| Sep 11 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 400 | 0 | 65,438 | 65 K to 65.4 K (+0.62 %) |
| Sep 11 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 850 | 0 | 65,038 | 64.2 K to 65 K (+1.32 %) |
| Sep 07 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 800 | 4,000 | 49,600 | |
| Sep 07 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 100 | 500 | 48,800 | |
| Sep 07 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 100 | 500 | 48,700 | |
| Sep 07 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 899 | 0 | 64,188 | 63.3 K to 64.2 K (+1.42 %) |
| Sep 07 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 800 | 0 | 63,289 | 62.5 K to 63.3 K (+1.28 %) |
| Sep 05 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 200 | 1,000 | 48,600 | |
| Sep 05 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 1,700 | 8,500 | 48,400 | |
| Sep 05 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 200 | 1,000 | 46,700 | |
| Sep 05 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 1,200 | 6,000 | 46,500 | |
| Sep 05 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 300 | 0 | 62,489 | 62.2 K to 62.5 K (+0.48 %) |
| Sep 05 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 1,600 | 0 | 62,189 | 60.6 K to 62.2 K (+2.64 %) |
| Sep 05 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 300 | 0 | 60,589 | 60.3 K to 60.6 K (+0.50 %) |
| Sep 05 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 1,412 | 0 | 60,289 | 58.9 K to 60.3 K (+2.40 %) |
| Aug 29 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 600 | 3,000 | 45,300 | |
| Aug 29 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 900 | 0 | 58,877 | 58 K to 58.9 K (+1.55 %) |
| Aug 28 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.24 | 1,000 | 4,243 | 12,000 | 11 K to 12 K (+9.09 %) |
| Aug 28 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.24 | 500 | 2,121 | 11,000 | 10.5 K to 11 K (+4.76 %) |
| Aug 28 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.24 | 500 | 2,120 | 10,500 | 10 K to 10.5 K (+5.00 %) |
| Aug 28 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.19 | 500 | 2,094 | 10,000 | 9.5 K to 10 K (+5.26 %) |
| Aug 28 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.17 | 500 | 2,087 | 9,500 | 9 K to 9.5 K (+5.56 %) |
| Aug 25 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 1,200 | 0 | 57,977 | 56.8 K to 58 K (+2.11 %) |
| Aug 25 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 7,900 | 0 | 56,777 | 48.9 K to 56.8 K (+16.16 %) |
| Aug 25 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 1,500 | 0 | 48,877 | 47.4 K to 48.9 K (+3.17 %) |
| Aug 25 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 7,500 | 0 | 47,377 | 39.9 K to 47.4 K (+18.81 %) |
| Aug 24 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.18 | 500 | 2,089 | 9,000 | 8.5 K to 9 K (+5.88 %) |
| Aug 24 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.17 | 500 | 2,085 | 8,500 | 8 K to 8.5 K (+6.25 %) |
| Aug 24 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.15 | 500 | 2,075 | 8,000 | 7.5 K to 8 K (+6.67 %) |
| Aug 24 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.12 | 500 | 2,062 | 7,500 | 7 K to 7.5 K (+7.14 %) |
| Aug 24 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.12 | 500 | 2,059 | 7,000 | 6.5 K to 7 K (+7.69 %) |
| Aug 24 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 3.90 | 500 | 1,952 | 6,500 | 6 K to 6.5 K (+8.33 %) |
| Aug 23 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.25 | 500 | 2,125 | 6,000 | 5.5 K to 6 K (+9.09 %) |
| Aug 23 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.24 | 500 | 2,121 | 5,500 | 5 K to 5.5 K (+10.00 %) |
| Aug 23 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.24 | 500 | 2,121 | 5,000 | 4.5 K to 5 K (+11.11 %) |
| Aug 23 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.24 | 500 | 2,118 | 4,500 | 4 K to 4.5 K (+12.50 %) |
| Aug 23 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.15 | 500 | 2,074 | 4,000 | 3.5 K to 4 K (+14.29 %) |
| Aug 23 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.12 | 500 | 2,062 | 3,500 | 3 K to 3.5 K (+16.67 %) |
| Aug 23 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.24 | 500 | 2,121 | 3,000 | 2.5 K to 3 K (+20.00 %) |
| Aug 23 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.24 | 1,000 | 4,241 | 2,500 | 1.5 K to 2.5 K (+66.67 %) |
| Aug 23 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.22 | 500 | 2,112 | 1,500 | 1,000 to 1.5 K (+50.00 %) |
| Aug 23 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.22 | 500 | 2,109 | 1,000 | 500 to 1,000 (+100.00 %) |
| Aug 23 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Buy | P | 4.09 | 500 | 2,046 | 500 | 0 to 500 |
| Aug 21 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 100 | 500 | 44,700 | |
| Aug 21 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 100 | 500 | 44,600 | |
| Aug 21 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 8,400 | 0 | 39,877 | 31.5 K to 39.9 K (+26.69 %) |
| Aug 21 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 0.00 | 1,800 | 0 | 31 | -1,769 to 31 (-101.75 %) |
| Aug 17 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 3.35 | 100 | 335 | 300 | 200 to 300 (+50.00 %) |
| Aug 17 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 3.30 | 100 | 330 | 200 | 100 to 200 (+100.00 %) |
| Aug 17 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 3.20 | 100 | 320 | 100 | 0 to 100 |
| Aug 17 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 3.30 | 285 | 941 | 285 | 0 to 285 |
| Aug 17 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 3.32 | 300 | 996 | 29,677 | 29.4 K to 29.7 K (+1.02 %) |
| Aug 17 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 3.29 | 400 | 1,316 | 29,377 | 29 K to 29.4 K (+1.38 %) |
| Aug 17 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 3.24 | 100 | 324 | 28,977 | 28.9 K to 29 K (+0.35 %) |
| Aug 17 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 3.20 | 500 | 1,600 | 28,877 | 28.4 K to 28.9 K (+1.76 %) |
| Aug 11 2017 | PAVM | PAVmed Inc. | Battleman David S. | Director | Option Exercise | A | 2.98 | 40,000 | 119,200 | 40,000 | |
| Mar 21 2017 | PAVM | PAVmed Inc. | MCGRATH DENNIS M | EVP & CFO | Option Exercise | A | 5.95 | 250,000 | 1,487,500 | 250,000 | |
| Jan 12 2017 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 25,000 | 125,000 | 44,500 | |
| Dec 02 2016 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 9.02 | 1,777 | 16,036 | 28,377 | 26.6 K to 28.4 K (+6.68 %) |
| Dec 02 2016 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 9.53 | 1,000 | 9,530 | 26,600 | 25.6 K to 26.6 K (+3.91 %) |
| Nov 28 2016 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 300 | 1,500 | 19,550 | |
| Nov 28 2016 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 8.98 | 2,200 | 19,767 | 25,600 | 23.4 K to 25.6 K (+9.40 %) |
| Nov 23 2016 | PAVM | PAVmed Inc. | Lamstein Joshua R | Director | Option Exercise | P | 5.00 | 100 | 500 | 100 | |
| Nov 22 2016 | PAVM | PAVmed Inc. | Lamstein Joshua R | Director | Buy | P | 11.51 | 100 | 1,151 | 100 | 0 to 100 |
| Nov 22 2016 | PAVM | PAVmed Inc. | Lamstein Joshua R | Director | Buy | P | 10.38 | 100 | 1,038 | 100 | 0 to 100 |
| Nov 22 2016 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 9.93 | 900 | 8,939 | 23,400 | 22.5 K to 23.4 K (+4.00 %) |
| Nov 22 2016 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 10.07 | 1,400 | 14,097 | 22,500 | 21.1 K to 22.5 K (+6.64 %) |
| Sep 19 2016 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Option Exercise | P | 5.00 | 100 | 500 | 19,250 | |
| Sep 19 2016 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 14.00 | 200 | 2,800 | 21,100 | 20.9 K to 21.1 K (+0.96 %) |
| Sep 19 2016 | PAVM | PAVmed Inc. | Aklog Lishan | Chairman and CEO | Buy | P | 13.74 | 200 | 2,747 | 20,900 | 20.7 K to 20.9 K (+0.97 %) |